Exploring the Comprehensive Kozak Sequence Landscape for AAV Production in Sf9 System

The widespread successful use of recombinant Adeno-associated virus (rAAV) in gene therapy has driven the demand for scale-up manufacturing methods of vectors with optimized yield and transduction efficiency. The Baculovirus/Sf9 system is a promising platform for high yield production; however, a ma...

Full description

Bibliographic Details
Main Authors: Oleksandr Kondratov, Sergei Zolotukhin
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/15/10/1983
_version_ 1797572087430250496
author Oleksandr Kondratov
Sergei Zolotukhin
author_facet Oleksandr Kondratov
Sergei Zolotukhin
author_sort Oleksandr Kondratov
collection DOAJ
description The widespread successful use of recombinant Adeno-associated virus (rAAV) in gene therapy has driven the demand for scale-up manufacturing methods of vectors with optimized yield and transduction efficiency. The Baculovirus/Sf9 system is a promising platform for high yield production; however, a major drawback to using an invertebrate cell line compared to a mammalian system is a generally altered AAV capsid stoichiometry resulting in lower biological potency. Here, we introduce a term of the structural and biological “fitness” of an AAV capsid as a function of two interdependent parameters: (1) packaging efficiency (yield), and (2) transduction efficiency (infectivity). Both parameters are critically dependent on AAV capsid structural proteins VP1/2/3 stoichiometry. To identify an optimal AAV capsid composition, we developed a novel Directed Evolution (DE) protocol for assessing the structural and biological fitness of Sf9-manufactured rAAV for any given serotype. The approach involves the packaging of a combinatorial capsid library in insect Sf9 cells, followed by a library screening for high infectivity in human Cre–recombinase-expressing C12 cells. One single DE selection round, complemented by Next-Generation Sequencing (NGS) and guided by in silico analysis, identifies a small subset of VP1 translation initiation sites (known as Kozak sequence) encoding “fit” AAV capsids characterized by a high production yield and superior transduction efficiencies.
first_indexed 2024-03-10T20:49:46Z
format Article
id doaj.art-458938bd46814838b3b01f744179ad89
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T20:49:46Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-458938bd46814838b3b01f744179ad892023-11-19T18:26:25ZengMDPI AGViruses1999-49152023-09-011510198310.3390/v15101983Exploring the Comprehensive Kozak Sequence Landscape for AAV Production in Sf9 SystemOleksandr Kondratov0Sergei Zolotukhin1Division of Cellular and Molecular Therapy, Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL 32610, USADivision of Cellular and Molecular Therapy, Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL 32610, USAThe widespread successful use of recombinant Adeno-associated virus (rAAV) in gene therapy has driven the demand for scale-up manufacturing methods of vectors with optimized yield and transduction efficiency. The Baculovirus/Sf9 system is a promising platform for high yield production; however, a major drawback to using an invertebrate cell line compared to a mammalian system is a generally altered AAV capsid stoichiometry resulting in lower biological potency. Here, we introduce a term of the structural and biological “fitness” of an AAV capsid as a function of two interdependent parameters: (1) packaging efficiency (yield), and (2) transduction efficiency (infectivity). Both parameters are critically dependent on AAV capsid structural proteins VP1/2/3 stoichiometry. To identify an optimal AAV capsid composition, we developed a novel Directed Evolution (DE) protocol for assessing the structural and biological fitness of Sf9-manufactured rAAV for any given serotype. The approach involves the packaging of a combinatorial capsid library in insect Sf9 cells, followed by a library screening for high infectivity in human Cre–recombinase-expressing C12 cells. One single DE selection round, complemented by Next-Generation Sequencing (NGS) and guided by in silico analysis, identifies a small subset of VP1 translation initiation sites (known as Kozak sequence) encoding “fit” AAV capsids characterized by a high production yield and superior transduction efficiencies.https://www.mdpi.com/1999-4915/15/10/1983rAAVKozakSf9packagingtransductiondirected evolution
spellingShingle Oleksandr Kondratov
Sergei Zolotukhin
Exploring the Comprehensive Kozak Sequence Landscape for AAV Production in Sf9 System
Viruses
rAAV
Kozak
Sf9
packaging
transduction
directed evolution
title Exploring the Comprehensive Kozak Sequence Landscape for AAV Production in Sf9 System
title_full Exploring the Comprehensive Kozak Sequence Landscape for AAV Production in Sf9 System
title_fullStr Exploring the Comprehensive Kozak Sequence Landscape for AAV Production in Sf9 System
title_full_unstemmed Exploring the Comprehensive Kozak Sequence Landscape for AAV Production in Sf9 System
title_short Exploring the Comprehensive Kozak Sequence Landscape for AAV Production in Sf9 System
title_sort exploring the comprehensive kozak sequence landscape for aav production in sf9 system
topic rAAV
Kozak
Sf9
packaging
transduction
directed evolution
url https://www.mdpi.com/1999-4915/15/10/1983
work_keys_str_mv AT oleksandrkondratov exploringthecomprehensivekozaksequencelandscapeforaavproductioninsf9system
AT sergeizolotukhin exploringthecomprehensivekozaksequencelandscapeforaavproductioninsf9system